Tests with proven value in diagnosis of COVID-19

  • Zahid Hussain Khan Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Shahram Samadi Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Jalil Makarem Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Seyed Mohamad Mireskandari Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Keywords:
COVID-19; Diagnostic tests; Lockdown

Abstract

COVID-19 has literally ravaged the entire world. People from all walks of life are badly affected because of compulsory lockdown around the world. Timely diagnosis is a problem as there is no single test that can achieve the highest acceptable sensitivity. Some of the tests are indeed costly and footing the bill by the governments can cause a tremendous load on the Treasury. As it stands, the current tests are beyond patient means and, thus, the patient would never have it performed. Lastly, there is no consensus as to whether everyone should be tested for COVID-19 and not based on presence of clinical features.Unfortunately, since the disease has been declared a pandemic, all should be considered to be infected unless provenotherwise by the tests that are performed.

References

1. Chan JF, Yip CC, To KK, Tang TH, Wong SC , Leung KH, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol 2020;58(5): e00310-20.
2. Khan S, Nabi G, Han G, Siddique R, Lian S, Shi H, et al. Novel coronavirus: how the things are in Wuhan. Clin Microbiol Infect 2020;26:399-400.
3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 hospitalized patients with novel 2019 coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323:1061-1069.
4. Ai T, Yang Z, Hou H , Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 2020; 200642. doi: 10.1148/radiol.2020200642.
5. Chung M, BernheimA, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019- n Cov). Radiology 2020;295:202-207.
6. Mounesan L, Eybpoosh S, Haghdoost AA, Moradi G, Mostafavi E. Is reporting many cases of COVID-19 in Iran due to strenghth or weakness of Iran's health system? Iran J Microbiol 2020; 12: 73-76.
Published
2020-05-29
How to Cite
1.
Khan ZH, Samadi S, Makarem J, Mireskandari SM. Tests with proven value in diagnosis of COVID-19. Iran J Microbiol. 12(3):261-262.
Section
Letter to the Editor